AddThis Sharing Buttons
Published October 6, 2017 by Joseph Gustaitis
Print Text Size: A A A
Many people with diabetes want to test their blood sugar levels regularly but don’t. The reason that most of them give is that they just don’t want to go through the unpleasant business of sticking their finger to draw blood. However, the U.S. Food and Drug Administration (FDA) has just approved a new technology that its manufacturer advertises as a breakthrough that “eliminates the need for routine fingersticks.”
The device is called the FreeStyle Libre Flash Glucose Monitoring System (FreeStyle Libre for short), and it’s the creation of Abbott, a global health-care company based in Illinois. The system checks blood glucose levels through a sensor that’s about the size of two stacked quarters. The user applies the waterproof sensor to the back of the upper arm. Once it’s in place, the user is able to scan it with a small handheld reader. The scan is painless and takes about a second. Because the scanner can make readings through clothing, the wearer doesn’t have to uncover the upper arm to get a reading.
Advertisement
.
The scan identifies glucose levels as high, low, or stable and provides an 8-hour history of fluctuations — in other words, the FreeStyle Libre essentially works as a continuous glucose monitor (CGM). The manufacturer says that the FreeStyle Libre is calibrated at the factory and therefore doesn’t require daily calibration by the user through fingersticks, as some other CGMs do. The device is especially recommended for people being treated with insulin, because these are the ones who require the most careful and frequent monitoring.
Although it has just been approved in the United States, the FreeStyle Libre has already been used by more than 400,000 people in about 40 countries. The manufacturer says reports indicate that users test their glucose levels at an average of at least 15 times a day, a frequency that leads to better overall glucose control. Abbott expects that the device will be available at U.S. pharmacies before the end of the year. To get one, a user will need a doctor’s prescription.
Recent ABT News
- Abbott Hosts Conference Call for Third-Quarter Earnings • PR Newswire (US) • 09/25/2024 01:00:00 PM
- Abbott Declares 403rd Consecutive Quarterly Dividend • PR Newswire (US) • 09/19/2024 04:59:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/13/2024 09:24:39 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/12/2024 10:20:12 PM
- Abbott's Lingo™ Continuous Glucose Monitor for Health and Wellness Now Available in the U.S. • PR Newswire (US) • 09/05/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/05/2024 12:03:07 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/04/2024 11:52:20 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/04/2024 08:04:41 PM
- Abbott Initiates Clinical Study to Evaluate the Use of Its Deep Brain Stimulation System to Manage Severe Depression • PR Newswire (US) • 09/04/2024 01:00:00 PM
- Abbott Expands its Pure Bliss™ Line of Infant Formulas to Include European-Made and Organic Products; Offers the First and Only Organic Liquid Formula Available at U.S. Retail Stores • PR Newswire (US) • 08/27/2024 01:00:00 PM
- AVEIR(MC) DR d'Abbott - Le premier système de stimulateur cardiaque double chambre sans sonde est maintenant offert au Canada • PR Newswire (Canada) • 08/15/2024 06:18:00 PM
- Abbott's AVEIR™ DR - World's First Dual Chamber Leadless Pacemaker System - Now Available in Canada • PR Newswire (Canada) • 08/15/2024 05:44:00 PM
- Québec élargit sa couverture publique du système flash de surveillance du glucose FreeStyle Libre 2 à un plus grand nombre d'adultes atteints de diabète • PR Newswire (Canada) • 08/08/2024 01:00:00 PM
- Quebec Expands Public Reimbursement of Abbott's FreeStyle Libre® 2 Flash Glucose Monitoring System to More Adults with Diabetes • PR Newswire (Canada) • 08/08/2024 01:00:00 PM
- Abbott Enters Global Partnership to Connect Its World-Leading Continuous Glucose Monitoring System with Medtronic's Insulin Delivery Devices • PR Newswire (US) • 08/07/2024 12:00:00 PM
- Abbott Enters Global Partnership to Connect Its World-Leading Continuous Glucose Monitoring System with Medtronic's Insulin Delivery Devices • PR Newswire (US) • 08/07/2024 12:00:00 PM
- Cadrenal Therapeutics and Abbott Initiate Collaborative Effort to Advance Novel Anticoagulant Tecarfarin for Patients with LVADs • PR Newswire (US) • 08/06/2024 01:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/31/2024 08:02:17 PM
- Apple Delays AI Features, Abbott Shares Plunge 7% After $495M Fine, Philips Soars 10% • IH Market News • 07/29/2024 10:24:10 AM
- Microsoft Shares Drop 2% and CrowdStrike Plunges 21% Pre-Market Following Major Global Outage • IH Market News • 07/19/2024 10:01:22 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/18/2024 11:37:35 AM
- Abbott Reports Second-Quarter 2024 Results and Raises Full-Year Guidance • PR Newswire (US) • 07/18/2024 11:30:00 AM
- Nasdaq Tech Stocks Show Partial Recovery; Oil Prices Rise • IH Market News • 07/18/2024 10:01:11 AM
- BP Slashes Profit Forecast by $700 Million; Morgan Stanley Predicts S&P 500 10% Drop, and More News • IH Market News • 07/09/2024 10:54:32 AM
- Abbott Hosts Conference Call for Second-Quarter Earnings • PR Newswire (US) • 06/27/2024 12:00:00 PM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM